Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cadrenal Therapeutics, Inc.CVKD · Entity 8251 | Director | October 09, 2026 | October 13, 2026 |
| O REILLY AUTOMOTIVE INCORLY · Entity 2977 | Director | May 18, 2026 | May 20, 2026 |
| Summit Materials, Inc.SUM · Entity 16259 | Director | September 29, 2023 | October 02, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cadrenal Therapeutics, Inc.
Report date October 09, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.91 · Expires 2036-10-08 | Direct | 75,000 |
Reported balance
After 2026-10-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-09 · Grant · Acquired 75,000 · Balance 75,000 F1: The stock options have a grant date of October 9, 2026 under the Issuer's 2022 Successor Equity Incentive Plan, were fully vested and immediately exercisable on the date of grant, and have an exercise price equal to the closing price of the Issuer's common stock on October 9, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options have a grant date of October 9, 2026 under the Issuer's 2022 Successor Equity Incentive Plan, were fully vested and immediately exercisable on the date of grant, and have an exercise price equal to the closing price of the Issuer's common stock on October 9, 2026.
O REILLY AUTOMOTIVE INC
Report date May 18, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 4,000 |
Reported balance
After 2026-05-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-18 · Sale · Disposed 2,595 · Balance 4,000 F1: Total includes 2,035 unvested restricted share awards and 1,965 shares held directly by Mr. Murphy. |
| Common stockSEC Table I · non-derivative | IndirectIndirectly in an IRA. | 8,125 |
Reported balance
Holding disclosure · report date 2026-05-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 8,125 |
Filing footnotes · ownership attribution and instrument terms
F1: Total includes 2,035 unvested restricted share awards and 1,965 shares held directly by Mr. Murphy.
Summit Materials, Inc.
Report date September 29, 2023 · Filed October 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 21,499 |
Reported balance
After 2023-09-29 transaction · row 1
1 source rowRow 1 · 2023-09-29 · Conversion · Acquired 4,274 · Balance 21,499 F1: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the Issuer's Class A common stock on a one-for-one basis. |
| LP Units of Summit Materials Holdings L.P.SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-09-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-09-29 · Conversion · Disposed 4,274 · Balance 0 F1: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the Issuer's Class A common stock on a one-for-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the Issuer's Class A common stock on a one-for-one basis.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Apria, Inc.
Report date March 29, 2022 · Filed March 29, 2022
Section 16 reporting ended · disclosed 2022-03-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $5.33 · Expires 2029-10-08 | Direct | 0 |
Reported balance
After 2022-03-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-03-29 · Disposition to issuer · Disposed 13,799 · Balance 0 F1: On March 29, 2022, Owens & Minor, Inc. ("Owens & Minor") acquired the Issuer pursuant to a certain Agreement and Plan of Merger, dated as of January 7, 2022 (the "Merger Agreement"), by and among the Issuer, Owens & Minor and StoneOak Merger Sub Inc., an indirect, wholly owned subsidiary of Owens & Minor ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as an indirect, wholly owned subsidiary of Owens & Minor. At the effective time of the Merger, each issued and outstanding share of the Issuer's Common Stock (other than certain excluded shares) automatically converted into the right to receive $37.50 per share in cash (the "Merger Consideration"), without interest and subject to applicable withholding tax. F2: Pursuant to the Merger Agreement, these stock appreciation rights which originally provided for vesting in equal quarterly installments until August 15, 2024, became fully vested and canceled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the difference between the conversion price of the stock appreciation right and the Merger Consideration multiplied by the number of shares of Common Stock subject to such stock appreciation right, immediately prior to the effective time of the Merger. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $5.33 · Expires 2030-05-12 | Direct | 0 |
Reported balance
After 2022-03-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-29 · Disposition to issuer · Disposed 17,249 · Balance 0 F1: On March 29, 2022, Owens & Minor, Inc. ("Owens & Minor") acquired the Issuer pursuant to a certain Agreement and Plan of Merger, dated as of January 7, 2022 (the "Merger Agreement"), by and among the Issuer, Owens & Minor and StoneOak Merger Sub Inc., an indirect, wholly owned subsidiary of Owens & Minor ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as an indirect, wholly owned subsidiary of Owens & Minor. At the effective time of the Merger, each issued and outstanding share of the Issuer's Common Stock (other than certain excluded shares) automatically converted into the right to receive $37.50 per share in cash (the "Merger Consideration"), without interest and subject to applicable withholding tax. F3: Pursuant to the Merger Agreement, these stock appreciation rights which originally provided for vesting as follows: (a) 20% vest on May 12, 2021, and (b) the remaining to vest in equal quarterly installments ending on May 12, 2025, became fully vested and canceled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the difference between the conversion price of the stock appreciation right and the Merger Consideration multiplied by the number of shares of Common Stock subject to such stock appreciation right, immediately prior to the effective time of the Merger. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-03-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-03-29 · Disposition to issuer · Disposed 5,059 · Balance 0 F4: Represents a contingent right to receive one share of the Issuer's Common Stock payable in Common Stock, cash or a combination thereof at the discretion of the Issuer's Compensation Committee. F1: On March 29, 2022, Owens & Minor, Inc. ("Owens & Minor") acquired the Issuer pursuant to a certain Agreement and Plan of Merger, dated as of January 7, 2022 (the "Merger Agreement"), by and among the Issuer, Owens & Minor and StoneOak Merger Sub Inc., an indirect, wholly owned subsidiary of Owens & Minor ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as an indirect, wholly owned subsidiary of Owens & Minor. At the effective time of the Merger, each issued and outstanding share of the Issuer's Common Stock (other than certain excluded shares) automatically converted into the right to receive $37.50 per share in cash (the "Merger Consideration"), without interest and subject to applicable withholding tax. F5: Pursuant to the Merger Agreement, each restricted stock unit ("RSU") became fully vested and cancelled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the number of shares of Common Stock subject to such RSU, immediately prior to the effective time of the Merger, multiplied by the Merger Consideration. F6: Represents RSUs granted in 2021, which were originally scheduled to vest on the earlier of (i) June 10, 2022 and (ii) the first regularly scheduled annual meeting of the stockholders of the Company following the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 29, 2022, Owens & Minor, Inc. ("Owens & Minor") acquired the Issuer pursuant to a certain Agreement and Plan of Merger, dated as of January 7, 2022 (the "Merger Agreement"), by and among the Issuer, Owens & Minor and StoneOak Merger Sub Inc., an indirect, wholly owned subsidiary of Owens & Minor ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as an indirect, wholly owned subsidiary of Owens & Minor. At the effective time of the Merger, each issued and outstanding share of the Issuer's Common Stock (other than certain excluded shares) automatically converted into the right to receive $37.50 per share in cash (the "Merger Consideration"), without interest and subject to applicable withholding tax.
F2: Pursuant to the Merger Agreement, these stock appreciation rights which originally provided for vesting in equal quarterly installments until August 15, 2024, became fully vested and canceled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the difference between the conversion price of the stock appreciation right and the Merger Consideration multiplied by the number of shares of Common Stock subject to such stock appreciation right, immediately prior to the effective time of the Merger.
F3: Pursuant to the Merger Agreement, these stock appreciation rights which originally provided for vesting as follows: (a) 20% vest on May 12, 2021, and (b) the remaining to vest in equal quarterly installments ending on May 12, 2025, became fully vested and canceled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the difference between the conversion price of the stock appreciation right and the Merger Consideration multiplied by the number of shares of Common Stock subject to such stock appreciation right, immediately prior to the effective time of the Merger.
F4: Represents a contingent right to receive one share of the Issuer's Common Stock payable in Common Stock, cash or a combination thereof at the discretion of the Issuer's Compensation Committee.
F5: Pursuant to the Merger Agreement, each restricted stock unit ("RSU") became fully vested and cancelled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the number of shares of Common Stock subject to such RSU, immediately prior to the effective time of the Merger, multiplied by the Merger Consideration.
F6: Represents RSUs granted in 2021, which were originally scheduled to vest on the earlier of (i) June 10, 2022 and (ii) the first regularly scheduled annual meeting of the stockholders of the Company following the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2026 Filed Oct 13, 2026 21:32 UTC | Cadrenal Therapeutics, Inc. CVKD · Entity 8251 | GrantStock Option · Derivative | 75,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001213900-26-109130 · ownership.xml · derivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2036-10-08 F1 · shares: The stock options have a grant date of October 9, 2026 under the Issuer's 2022 Successor Equity Incentive Plan, were fully vested and immediately exercisable on the date of grant, and have an exercise price equal to the closing price of the Issuer's common stock on October 9, 2026. F1 · derivative.exercise_date: The stock options have a grant date of October 9, 2026 under the Issuer's 2022 Successor Equity Incentive Plan, were fully vested and immediately exercisable on the date of grant, and have an exercise price equal to the closing price of the Issuer's common stock on October 9, 2026. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:32 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | SaleCommon stock | 2,595 | $88.67 | $230,098.65 |
DisclosureSEC source: 0001275195-26-000004 · form4-05202026_080509.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 F1 · balance_after: Total includes 2,035 unvested restricted share awards and 1,965 shares held directly by Mr. Murphy. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:42 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | GrantCommon stock | 2,035 | $88.49 | $180,077.15 |
DisclosureSEC source: 0001275195-26-000002 · form4-05182026_080537.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,595 F1 · shares: Represents a restricted share award, which vests in one installment on May 13, 2027. F2 · balance_after: Total includes 2,035 unvested restricted share awards and 4,560 shares held directly by Mr. Murphy. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 21:35 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | SaleCommon stock | 3,125 | $92.60 | $289,376.25 |
DisclosureSEC source: 0001275195-25-000004 · form4-11062025_091132.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Indirectly in an IRA. Disclosed balance after: 8,125 Read SEC document |
| May 19, 2025 Filed May 20, 2025 20:41 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | SaleCommon stock | 200 | $1,379.00 | $275,800.00 |
DisclosureSEC source: 0001415889-25-013813 · form4-05202025_080510.xml · nonDerivative · entry 2 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 304 F2 · balance_after: Total includes 131 unvested restricted share awards and 173 shares held directly by Mr. Murphy. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:41 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | GrantCommon stock | 131 | $1,381.66 | $180,997.46 |
DisclosureSEC source: 0001415889-25-013813 · form4-05202025_080510.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 504 F1 · shares: Represents a restricted share award, which vests in one installment on May 14, 2026. Read SEC document |
| January 23, 2025 Filed Jan 24, 2025 23:13 UTC | Cadrenal Therapeutics, Inc. CVKD · Entity 8251 | GrantStock Options · Derivative | 20,000 | $0.00 Strike: $19.79 | $0.00 |
DisclosureSEC source: 0001213900-25-006640 · ownership.xml · derivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2035-01-22 F1 · security: These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2025. Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:33 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | GrantCommon stock | 173 | $1,012.06 | $175,086.38 |
DisclosureSEC source: 0001415889-24-013958 · form4-05212024_080550.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,123 F1 · shares: Represents a restricted share award, which vests in one installment on May 15, 2025. F2 · balance_after: Total includes 173 unvested restricted share awards and 950 shares held directly by Mr. Murphy. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:46 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | SaleCommon stock | 269 | $1,039.28 | $279,567.15 |
DisclosureSEC source: 0001415889-24-003933 · form4-02152024_090217.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 950 F1 · balance_after: Total includes 169 unvested restricted share awards and 781 shares held directly by Mr. Murphy. Read SEC document |
| January 18, 2024 Filed Jan 20, 2024 00:41 UTC | Cadrenal Therapeutics, Inc. CVKD · Entity 8251 | GrantStock Options · Derivative | 100,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001213900-24-005003 · ownership.xml · derivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-01-17 F1 · security: These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2024 and vesting fully on January 18, 2025. F1 · derivative.exercise_date: These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2024 and vesting fully on January 18, 2025. Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 20:36 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | SaleCommon stock | 250 | $929.67 | $232,416.25 |
DisclosureSEC source: 0001415889-23-014708 · form4-11022023_081105.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,219 F1 · balance_after: Total includes 169 unvested restricted share awards and 1,050 shares held directly by Mr. Murphy. Read SEC document |
| October 05, 2023 Filed Oct 6, 2023 21:32 UTC | Cadrenal Therapeutics, Inc. CVKD · Entity 8251 | PurchaseCommon Stock | 2,669 | $0.69 | $1,841.61 |
DisclosureSEC source: 0001213900-23-081216 · ownership.xml · nonDerivative · entry 2 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 614,792 Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 21:32 UTC | Cadrenal Therapeutics, Inc. CVKD · Entity 8251 | PurchaseCommon Stock | 17,331 | $0.70 | $12,131.70 |
DisclosureSEC source: 0001213900-23-081216 · ownership.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 612,123 Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 20:04 UTC | Summit Materials, Inc. SUM · Entity 16259 | ConversionLP Units of Summit Materials Holdings L.P. · Derivative | 4,274 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-033533 · wk-form4_1696291442.xml · derivative · entry 2 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,274 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the Issuer's Class A common stock on a one-for-one basis. F1 · price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.exercise_date: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the Issuer's Class A common stock on a one-for-one basis. F1 · derivative.expiration_date: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the Issuer's Class A common stock on a one-for-one basis. Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 20:04 UTC | Summit Materials, Inc. SUM · Entity 16259 | ConversionClass A Common Stock | 4,274 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-033533 · wk-form4_1696291442.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the Issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the Issuer's Class A common stock on a one-for-one basis. Read SEC document |
| May 19, 2023 Filed May 23, 2023 20:32 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | GrantCommon stock | 169 | $954.30 | $161,276.70 |
DisclosureSEC source: 0001415889-23-008612 · form4-05232023_080549.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,469 F1 · shares: Represents a restricted share award, which vests in one installment on May 16, 2024. F2 · balance_after: Total includes 169 unvested restricted share awards and 1,300 shares held directly by Mr. Murphy. Read SEC document |
| May 02, 2023 Filed May 4, 2023 21:39 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | SaleCommon stock | 300 | $924.56 | $277,368.00 |
DisclosureSEC source: 0001415889-23-007364 · form4-05042023_090531.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,300 F1 · balance_after: Total includes 248 unvested restricted share awards and 1,052 shares held directly by Mr. Murphy. Read SEC document |
| March 21, 2023 Filed Mar 22, 2023 20:01 UTC | Cadrenal Therapeutics, Inc. CVKD · Entity 8251 | PurchaseCommon Stock | 10,000 | $1.39 | $13,900.00 |
DisclosureSEC source: 0001213900-23-022065 · ownership.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 594,792 F1 · balance_after: The amount of securities beneficially owned by Mr. Murphy following the reported transaction is correctly reported on this Form 4. The amount of securities beneficially owned by Mr. Murphy has been adjusted to correct immaterial errors in prior Form 4 filings that were filed with the Securities and Exchange Commission on January 24, 2023 and March 16, 2023. Read SEC document |
| March 16, 2023 Filed Mar 16, 2023 21:27 UTC | Cadrenal Therapeutics, Inc. CVKD · Entity 8251 | PurchaseCommon Stock | 20,000 | $1.67 | $33,398.00 |
DisclosureSEC source: 0001213900-23-020675 · ownership.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 574,792 Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 17:34 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionRestricted Stock Units · Derivative | 3,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-005889 · wf-form4_167771004226779.xml · derivative · entry 2 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,815 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's Human Capital and Compensation Committee. F4 · derivative.exercise_date: On March 1, 2022, the Reporting Person was granted 3,815 restricted stock units that vested on February 28, 2023. F4 · derivative.expiration_date: On March 1, 2022, the Reporting Person was granted 3,815 restricted stock units that vested on February 28, 2023. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 17:34 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionClass A Common Stock | 3,815 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-005889 · wf-form4_167771004226779.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects restricted stock units that upon vesting converted into shares of Class A common stock of the Issuer ("Class A Common Stock") on a one-for-one basis. F2 · balance_after: Total holdings include shares of Class A Common Stock received pursuant to a stock dividend paid on December 29, 2022. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 18:49 UTC | Summit Materials, Inc. SUM · Entity 16259 | GrantRestricted Stock Units · Derivative | 4,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-005119 · wf-form4_167728255627005.xml · derivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,038 Underlying: Class A Common Stock · 4,038 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock of the Issuer ("Class A Common Stock"). The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's Human Capital and Compensation Committee. F2 · derivative.exercise_date: These restricted stock units vest on February 28, 2024. F2 · derivative.expiration_date: These restricted stock units vest on February 28, 2024. Read SEC document |
| February 14, 2023 Filed Feb 22, 2023 21:30 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | SaleCommon stock | 300 | $850.06 | $255,018.00 |
DisclosureSEC source: 0001415889-23-002987 · form4-02222023_090219.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 F1 · balance_after: Total includes 248 unvested restricted shares awards and 1,352 shares held directly by Mr. Murphy. Read SEC document |
| January 24, 2023 Filed Jan 24, 2023 22:00 UTC | Cadrenal Therapeutics, Inc. CVKD · Entity 8251 | ConversionConvertible Promissory Note · Derivative | 514,792 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0001213900-23-004882 · ownership.xml · derivative · entry 2 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 514,792 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon consummation of the initial public offering of Cadrenal Therapeutics, Inc. on January 24, 2023, Mr. Murphy was issued 514,792 shares of common stock pursuant to the conversion of a convertible promissory note in the principal amount of $500,000, based on a conversion price of $1.00 per share. F1 · derivative.exercise_date: Upon consummation of the initial public offering of Cadrenal Therapeutics, Inc. on January 24, 2023, Mr. Murphy was issued 514,792 shares of common stock pursuant to the conversion of a convertible promissory note in the principal amount of $500,000, based on a conversion price of $1.00 per share. F1 · derivative.expiration_date: Upon consummation of the initial public offering of Cadrenal Therapeutics, Inc. on January 24, 2023, Mr. Murphy was issued 514,792 shares of common stock pursuant to the conversion of a convertible promissory note in the principal amount of $500,000, based on a conversion price of $1.00 per share. Read SEC document |
| January 24, 2023 Filed Jan 24, 2023 22:00 UTC | Cadrenal Therapeutics, Inc. CVKD · Entity 8251 | ConversionCommon Stock | 514,792 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-23-004882 · ownership.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 554,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon consummation of the initial public offering of Cadrenal Therapeutics, Inc. on January 24, 2023, Mr. Murphy was issued 514,792 shares of common stock pursuant to the conversion of a convertible promissory note in the principal amount of $500,000, based on a conversion price of $1.00 per share. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:53 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | SaleCommon stock | 300 | $705.49 | $211,647.00 |
DisclosureSEC source: 0001415889-22-008269 · form4-08042022_010845.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 F1 · balance_after: Total includes 248 unvested restricted shares awards and 1,652 shares held directly by Mr. Murphy. Read SEC document |
| May 13, 2022 Filed May 17, 2022 19:53 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | GrantCommon stock | 248 | $635.62 | $157,633.76 |
DisclosureSEC source: 0001415889-22-005127 · form4-05172022_120529.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 F1 · shares: Represents a restricted share award, which vests in one installment on May 18, 2023. F2 · balance_after: Total includes 248 unvested restricted shares awards and 1,952 shares held directly by Mr. Murphy. Read SEC document |
| March 29, 2022 Filed Mar 29, 2022 20:30 UTC | Apria, Inc. APR · Entity 15495 | Disposition to issuerRestricted Stock Units · Derivative | 5,059 | $37.50 | $189,712.50 |
DisclosureSEC source: 0000899243-22-012657 · doc4.xml · derivative · entry 3 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,059 shares Expires not disclosed F4 · derivative.exercise_price: Represents a contingent right to receive one share of the Issuer's Common Stock payable in Common Stock, cash or a combination thereof at the discretion of the Issuer's Compensation Committee. F1 · kind: On March 29, 2022, Owens & Minor, Inc. ("Owens & Minor") acquired the Issuer pursuant to a certain Agreement and Plan of Merger, dated as of January 7, 2022 (the "Merger Agreement"), by and among the Issuer, Owens & Minor and StoneOak Merger Sub Inc., an indirect, wholly owned subsidiary of Owens & Minor ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as an indirect, wholly owned subsidiary of Owens & Minor. At the effective time of the Merger, each issued and outstanding share of the Issuer's Common Stock (other than certain excluded shares) automatically converted into the right to receive $37.50 per share in cash (the "Merger Consideration"), without interest and subject to applicable withholding tax. F5 · kind: Pursuant to the Merger Agreement, each restricted stock unit ("RSU") became fully vested and cancelled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the number of shares of Common Stock subject to such RSU, immediately prior to the effective time of the Merger, multiplied by the Merger Consideration. F5 · price: Pursuant to the Merger Agreement, each restricted stock unit ("RSU") became fully vested and cancelled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the number of shares of Common Stock subject to such RSU, immediately prior to the effective time of the Merger, multiplied by the Merger Consideration. F6 · derivative.exercise_date: Represents RSUs granted in 2021, which were originally scheduled to vest on the earlier of (i) June 10, 2022 and (ii) the first regularly scheduled annual meeting of the stockholders of the Company following the grant date. F6 · derivative.expiration_date: Represents RSUs granted in 2021, which were originally scheduled to vest on the earlier of (i) June 10, 2022 and (ii) the first regularly scheduled annual meeting of the stockholders of the Company following the grant date. Read SEC document |
| March 29, 2022 Filed Mar 29, 2022 20:30 UTC | Apria, Inc. APR · Entity 15495 | Disposition to issuerStock Appreciation Rights · Derivative | 17,249 | $32.17 Strike: $5.33 | $554,900.33 |
DisclosureSEC source: 0000899243-22-012657 · doc4.xml · derivative · entry 2 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,249 shares Expires 2030-05-12 F1 · kind: On March 29, 2022, Owens & Minor, Inc. ("Owens & Minor") acquired the Issuer pursuant to a certain Agreement and Plan of Merger, dated as of January 7, 2022 (the "Merger Agreement"), by and among the Issuer, Owens & Minor and StoneOak Merger Sub Inc., an indirect, wholly owned subsidiary of Owens & Minor ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as an indirect, wholly owned subsidiary of Owens & Minor. At the effective time of the Merger, each issued and outstanding share of the Issuer's Common Stock (other than certain excluded shares) automatically converted into the right to receive $37.50 per share in cash (the "Merger Consideration"), without interest and subject to applicable withholding tax. F3 · kind: Pursuant to the Merger Agreement, these stock appreciation rights which originally provided for vesting as follows: (a) 20% vest on May 12, 2021, and (b) the remaining to vest in equal quarterly installments ending on May 12, 2025, became fully vested and canceled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the difference between the conversion price of the stock appreciation right and the Merger Consideration multiplied by the number of shares of Common Stock subject to such stock appreciation right, immediately prior to the effective time of the Merger. F3 · price: Pursuant to the Merger Agreement, these stock appreciation rights which originally provided for vesting as follows: (a) 20% vest on May 12, 2021, and (b) the remaining to vest in equal quarterly installments ending on May 12, 2025, became fully vested and canceled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the difference between the conversion price of the stock appreciation right and the Merger Consideration multiplied by the number of shares of Common Stock subject to such stock appreciation right, immediately prior to the effective time of the Merger. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, these stock appreciation rights which originally provided for vesting as follows: (a) 20% vest on May 12, 2021, and (b) the remaining to vest in equal quarterly installments ending on May 12, 2025, became fully vested and canceled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the difference between the conversion price of the stock appreciation right and the Merger Consideration multiplied by the number of shares of Common Stock subject to such stock appreciation right, immediately prior to the effective time of the Merger. Read SEC document |
| March 29, 2022 Filed Mar 29, 2022 20:30 UTC | Apria, Inc. APR · Entity 15495 | Disposition to issuerStock Appreciation Rights · Derivative | 13,799 | $32.17 Strike: $5.33 | $443,913.83 |
DisclosureSEC source: 0000899243-22-012657 · doc4.xml · derivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,799 shares Expires 2029-10-08 F1 · kind: On March 29, 2022, Owens & Minor, Inc. ("Owens & Minor") acquired the Issuer pursuant to a certain Agreement and Plan of Merger, dated as of January 7, 2022 (the "Merger Agreement"), by and among the Issuer, Owens & Minor and StoneOak Merger Sub Inc., an indirect, wholly owned subsidiary of Owens & Minor ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as an indirect, wholly owned subsidiary of Owens & Minor. At the effective time of the Merger, each issued and outstanding share of the Issuer's Common Stock (other than certain excluded shares) automatically converted into the right to receive $37.50 per share in cash (the "Merger Consideration"), without interest and subject to applicable withholding tax. F2 · kind: Pursuant to the Merger Agreement, these stock appreciation rights which originally provided for vesting in equal quarterly installments until August 15, 2024, became fully vested and canceled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the difference between the conversion price of the stock appreciation right and the Merger Consideration multiplied by the number of shares of Common Stock subject to such stock appreciation right, immediately prior to the effective time of the Merger. F2 · price: Pursuant to the Merger Agreement, these stock appreciation rights which originally provided for vesting in equal quarterly installments until August 15, 2024, became fully vested and canceled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the difference between the conversion price of the stock appreciation right and the Merger Consideration multiplied by the number of shares of Common Stock subject to such stock appreciation right, immediately prior to the effective time of the Merger. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, these stock appreciation rights which originally provided for vesting in equal quarterly installments until August 15, 2024, became fully vested and canceled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the difference between the conversion price of the stock appreciation right and the Merger Consideration multiplied by the number of shares of Common Stock subject to such stock appreciation right, immediately prior to the effective time of the Merger. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:18 UTC | Summit Materials, Inc. SUM · Entity 16259 | GrantRestricted Stock Units · Derivative | 3,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-004911 · wf-form4_164634223593022.xml · derivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,815 Underlying: Class A Common Stock · 3,815 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock of the Issuer ("Class A Common Stock"). The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's Human Capital and Compensation Committee. F2 · derivative.exercise_date: These restricted stock units vest on February 28, 2023. F2 · derivative.expiration_date: These restricted stock units vest on February 28, 2023. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 17:47 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionRestricted Stock Units · Derivative | 4,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-004578 · wf-form4_164617481569755.xml · derivative · entry 2 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,374 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's Human Capital and Compensation Committee. F3 · derivative.exercise_date: On March 30, 2021, the Reporting Person was granted 4,374 restricted stock units that vested on February 28, 2022. F3 · derivative.expiration_date: On March 30, 2021, the Reporting Person was granted 4,374 restricted stock units that vested on February 28, 2022. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 17:47 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionClass A Common Stock | 4,374 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-004578 · wf-form4_164617481569755.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects restricted stock units that upon vesting converted into shares of Class A common stock of the Issuer ("Class A Common Stock") on a one-for-one basis. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 01:37 UTC | Apria, Inc. APR · Entity 15495 | SaleCommon Stock | 12,354 | $37.20 | $459,568.80 |
DisclosureSEC source: 0000899243-22-002752 · doc4.xml · nonDerivative · entry 7 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $37.15 to $37.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 01:37 UTC | Apria, Inc. APR · Entity 15495 | Exercise / conversionStock Appreciation Rights · Derivative | 5,750 | $0.00 Strike: $5.33 | $0.00 |
DisclosureSEC source: 0000899243-22-002752 · doc4.xml · derivative · entry 10 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,249 Underlying: Common Stock · 5,750 shares Expires 2030-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Represents an original grant of 22,999 stock appreciation rights, vest as follows: (a) 20% vested on May 12, 2021, and (b) the remaining vests in equal quarterly installments ending on May 12, 2025. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 01:37 UTC | Apria, Inc. APR · Entity 15495 | Exercise / conversionStock Appreciation Rights · Derivative | 5,750 | $0.00 Strike: $8.28 | $0.00 |
DisclosureSEC source: 0000899243-22-002752 · doc4.xml · derivative · entry 9 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,750 shares Expires 2029-10-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These stock appreciation rights are fully vested. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 01:37 UTC | Apria, Inc. APR · Entity 15495 | Exercise / conversionStock Appreciation Rights · Derivative | 3,450 | $0.00 Strike: $5.33 | $0.00 |
DisclosureSEC source: 0000899243-22-002752 · doc4.xml · derivative · entry 8 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,799 Underlying: Common Stock · 3,450 shares Expires 2029-10-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents an original grant of 17,249 stock appreciation rights, which vest in equal quarterly installments ending on August 15, 2024. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 01:37 UTC | Apria, Inc. APR · Entity 15495 | Tax withholdingCommon Stock | 823 | $37.24 | $30,648.52 |
DisclosureSEC source: 0000899243-22-002752 · doc4.xml · nonDerivative · entry 6 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,354 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 01:37 UTC | Apria, Inc. APR · Entity 15495 | Exercise / conversionCommon Stock | 5,750 | $5.33 | $30,647.50 |
DisclosureSEC source: 0000899243-22-002752 · doc4.xml · nonDerivative · entry 5 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 01:37 UTC | Apria, Inc. APR · Entity 15495 | Tax withholdingCommon Stock | 1,279 | $37.24 | $47,629.96 |
DisclosureSEC source: 0000899243-22-002752 · doc4.xml · nonDerivative · entry 4 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,427 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 01:37 UTC | Apria, Inc. APR · Entity 15495 | Exercise / conversionCommon Stock | 5,750 | $8.28 | $47,610.00 |
DisclosureSEC source: 0000899243-22-002752 · doc4.xml · nonDerivative · entry 3 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 01:37 UTC | Apria, Inc. APR · Entity 15495 | Tax withholdingCommon Stock | 494 | $37.24 | $18,396.56 |
DisclosureSEC source: 0000899243-22-002752 · doc4.xml · nonDerivative · entry 2 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,956 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 01:37 UTC | Apria, Inc. APR · Entity 15495 | Exercise / conversionCommon Stock | 3,450 | $5.33 | $18,388.50 |
DisclosureSEC source: 0000899243-22-002752 · doc4.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021. Read SEC document |
| November 08, 2021 Filed Nov 9, 2021 21:43 UTC | Summit Materials, Inc. SUM · Entity 16259 | SaleClass A Common Stock | 5,137 | $37.99 | $195,154.63 |
DisclosureSEC source: 0001628280-21-022670 · wf-form4_163651217862126.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,842 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $37.98 to $38.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The Reporting Person remains within compliance of the Issuer's equity ownership guidelines. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 23:47 UTC | Apria, Inc. APR · Entity 15495 | GrantRestricted Stock Units · Derivative | 5,059 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-023703 · doc4.xml · derivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,059 Underlying: Common Stock · 5,059 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer ("Common Stock"). The restricted stock units will be settled in either Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F2 · derivative.exercise_date: These restricted stock units vest on the earlier of (i) June 10, 2022 and (ii) the first regularly scheduled annual meeting of the stockholders of the Company following the grant date. F2 · derivative.expiration_date: These restricted stock units vest on the earlier of (i) June 10, 2022 and (ii) the first regularly scheduled annual meeting of the stockholders of the Company following the grant date. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:36 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | GrantCommon stock | 272 | $553.33 | $150,505.76 |
DisclosureSEC source: 0001415889-21-002540 · form4-05182021_010532.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,952 F1 · shares: Represents a restricted share award, which vests in one installment on May 14, 2022. F2 · balance_after: Total includes 399 unvested restricted share awards and 1,553 shares held directly by Mr. Murphy. Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:25 UTC | O REILLY AUTOMOTIVE INC ORLY · Entity 2977 | SaleCommon stock | 472 | $561.84 | $265,186.12 |
DisclosureSEC source: 0001415889-21-002420 · form4-05122021_010509.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 F1 · balance_after: Total includes 484 unvested restricted shares awards and 1,196 shares held directly by Mr. Murphy. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 21:30 UTC | Summit Materials, Inc. SUM · Entity 16259 | GrantRestricted Stock Units · Derivative | 4,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-045798 · tm2111872-13_4seq1.xml · derivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,374 Underlying: Class A Common Stock · 4,374 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock of the Issuer ("Class A Common Stock"). The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F2 · derivative.exercise_date: These restricted stock units vest on February 28, 2022. F2 · derivative.expiration_date: These restricted stock units vest on February 28, 2022. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 21:26 UTC | Summit Materials, Inc. SUM · Entity 16259 | SaleClass A Common Stock | 7,000 | $27.64 | $193,480.00 |
DisclosureSEC source: 0001104659-21-039886 · tm2110456-3_4seq1.xml · nonDerivative · entry 1 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,979 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.378 to $27.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The Reporting Person remains within compliance of the Issuer's equity ownership guidelines. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:26 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionRestricted Stock Units · Derivative | 5,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-030931 · a4.xml · derivative · entry 2 MURPHY JOHN RAYMOND · CIK 0001275195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,342 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F3 · derivative.exercise_date: On February 28, 2020, the Reporting Person was granted 5,342 restricted stock units that vested on February 28, 2021. F3 · derivative.expiration_date: On February 28, 2020, the Reporting Person was granted 5,342 restricted stock units that vested on February 28, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.